2008
DOI: 10.1016/j.brainres.2007.12.066
|View full text |Cite
|
Sign up to set email alerts
|

PPADS, a purinergic antagonist reduces Fos expression at spinal cord level in a mouse model of mononeuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 56 publications
1
7
0
Order By: Relevance
“…In line with the present study, localized application of PPADS effectively attenuated carrageenan‐ or postoperative‐induced spontaneous nociceptive responses in rats . In addition, intrathecal or systemic administration of PPADS markedly suppressed formalin and chronic nerve constriction nociceptive responses induced by injuries in mice . Moreover, peripheral P2X 3 and P2Y receptors are involved in the maintenance of melittin‐induced persistent pain, as melittin is the major component (50%) of BV and contributes to the BV‐evoked nociception .…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…In line with the present study, localized application of PPADS effectively attenuated carrageenan‐ or postoperative‐induced spontaneous nociceptive responses in rats . In addition, intrathecal or systemic administration of PPADS markedly suppressed formalin and chronic nerve constriction nociceptive responses induced by injuries in mice . Moreover, peripheral P2X 3 and P2Y receptors are involved in the maintenance of melittin‐induced persistent pain, as melittin is the major component (50%) of BV and contributes to the BV‐evoked nociception .…”
Section: Discussionsupporting
confidence: 88%
“…24,25 In addition, intrathecal or systemic administration of PPADS markedly suppressed formalin and chronic nerve constriction nociceptive responses induced by injuries in mice. 16,[26][27][28] Moreover, peripheral P2X 3 and P2Y receptors are involved in the maintenance of melittin-induced persistent pain, 29 as melittin is the major component (50%) of BV and contributes to the BV-evoked nociception. 10,[30][31][32] The results of the present study support the findings described above.…”
Section: Discussionmentioning
confidence: 99%
“…Other data from the literature suggest the role of PPADS in antinociception. The intraperitoneal administration of PPADS after chronic constriction injury of the sciatic nerve inhibits both thermal hyperalgesia and mechanical allodynia (Borsani et al, 2008; Martucci et al, 2008), and intrathecal pretreatment significantly suppresses both the first and the second phase of FORM‐related behavior (Tsuda et al, 1999). Moreover, because both phases of FORM‐evoked nociceptive behaviors were potentiated by a selective allosteric enhancer of P2X 3 receptor function (Jarvis et al, 2002), the involvement of P2X 3 receptors in acute and inflammatory pain is very likely.…”
Section: Discussionmentioning
confidence: 99%
“…Such requirements could be addressed by new information on the neuronal mechanisms of this pathology. The availability of animal models for this condition has permitted us to observe related morphological and molecular alteration in both the central, [ 1 , 2 , 3 ] and the peripheral nervous systems [ 2 , 4 , 5 , 6 ]. Moreover, a link between the impairment of the nervous system and an alteration of skin homeostasis (morphology and expression of molecular markers involved in nociception) has been demonstrated during neuropathic pathologies [ 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%